MedTrace Logo

Study of the 532 nm KTP Laser for the Treatment of Poikiloderma of Civatte

NCT01491620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-10-28

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety and efficacy of the Excel V 532 nm KTP laser for the treatment of dyschromia of the neck and/or chest (poikiloderma of Civatte).

Conditions

  • Poikiloderma of Civatte
  • Dyschromia
  • Pigmentation Disorders
  • Telangiectasia
  • Photosensitivity Disorders

Interventions

DEVICE

532 nm KTP laser

Laser treatment sessions on the neck and/or chest

Sponsors & Collaborators

  • Cutera Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01491620 on ClinicalTrials.gov